NEW YORK (Reuters Health) – Active surveillance (“watchful waiting”) of small renal masses offers short term results equivalent to those with immediate surgery, researchers from UK report in…
NEW YORK (Reuters Health) – Once-daily mesalamine, at a dose of 2.4 g, offers maintenance of remission of ulcerative colitis similar to that provided by twice-daily mesalamine at…
NEW YORK (Reuters Health) – Although liver transplantation for acute liver failure (ALF) still has a high early mortality, outcomes in Europe have improved over 2 decades, researchers…
NEW YORK (Reuters Health) – A long-term dietary intervention with grape resveratrol supplements improves the inflammatory and fibrinolytic status of patients at high risk of cardiovascular (CVD) disease,…
NEW YORK (Reuters Health) – On May 8, a panel of advisers to the US Food and Drug Administration unanimously voted against rilonacept (Arcalyst, Regeneron Pharmaceuticals) for use…
NEW YORK (Reuters Health) – Regardless of dosage, frequency or route of administration, vitamin D3 (cholecalciferol) is more efficacious in raising serum 25 hydroxyvitamin D concentrations than vitamin…
NEW YORK (Reuters Health) – Three years after a group of women with stress urinary incontinence were treated with transobturator tension-free vaginal tape (TO-TVT), roughly three-quarters felt the…
NEW YORK (Reuters Health) – The combination of estrogen and raloxifene seems to reduce menopausal symptoms and appears not to increase the risk of endometrial hyperplasia, researchers from…
NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include…
NEW YORK (Reuters Health) – Based on the results of a randomized, double-blind trial, more adolescents with acute migraine become pain-free within 2 hours after taking a combination…
